You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 744 Assessment of safety and immunologic activity of nemvaleukin alfa in patients with advanced solid tumors treated with less frequent intravenous dosing (ARTISTRY-3)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
744 Assessment of safety and immunologic activity of nemvaleukin alfa in patients with advanced solid tumors treated with less frequent intravenous dosing (ARTISTRY-3)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023192014
Dec 20233205
Jan 202410505
Feb 20245803
Mar 20246003
Apr 20244002
May 20245004
Jun 20243400
Jul 20242402
Aug 20244205
Sep 20243801
Oct 20247406
Nov 20249209
Dec 20243808
Jan 202532013
Feb 2025702
Mar 2025006
Apr 2025004
May 2025004
Jun 2025002
Total918098